ArticleFrontiers in cardiovascular medicine2025
The relationship between the 3D electroanatomical mapping parameters of the left atrial posterior wall and the recurrence of paroxysmal atrial fibrillation.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary vein isolation (PVI) remains the cornerstone of catheter ablation in paroxysmal atrial fibrillation (PAF). However, the recurrence of AF after PVI needs further investigation. The left atrial posterior wall (LAPW) is embryologically related to the pulmonary vein and plays an important role in the initiation and maintenance of AF. This study aims to explore the relationship between the 3D electroanatomical mapping parameters of the LAPW and recurrence in patients with PAF. Methods: A retrospective analysis was conducted on patients with PAF who underwent PVI. Both clinical and procedural characteristics from the enrolled subjects were collected before PVI. 3D electroanatomical mapping anatomical and electrical parameters were measured and calculated in the CARTO system. Intergroup comparisons and multivariate logistic regression analysis were performed to demonstrate the relationship between the parameters of LAPW and AF recurrence. A combined prediction model for AF recurrence was constructed in this study. Results: A total of 120 patients were included in the final analysis. Among procedural characteristics, compared with Group 1 (no recurrence), there was a significantly larger posterior wall surface area (PWSA) ( Conclusions: This study demonstrates that both PWSA and PVLVA were independent risk factors for AF recurrence. Moreover, we proposed a model that combined the PWSA with the PVLVA to predict the recurrence of AF, which may provide an approach for screening patients with PAF who may require attention for the LAPW.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.